Economic Evaluation of a Web-Based Guided Self-Help Intervention for Employees With Depressive Symptoms: Results of a Randomized Controlled Trial

Journal of Occupational and Environmental Medicine
Anna S GeraedtsJudith Bosmans

Abstract

To evaluate the cost-effectiveness of a Web-based guided intervention compared with care as usual for employees with depressive symptoms. A total of 231 employees with depressive symptoms were randomized. Data were collected at baseline, 8 weeks, 6 months, and 12 months. Analyses were conducted from the societal and employer's perspective. At 12 months, a significant intervention effect on depressive symptoms was found. At a willingness to pay of 0 (€/unit of effect), the intervention's probabilities of cost-effectiveness were 0.62 (societal perspective) and 0.55 (employer's perspective). There was a 0.63 probability that the intervention resulted in a positive financial return for the employer. The intervention's cost-effectiveness with regard to depressive symptoms depends on the willingness to pay of societal and company decision makers as well as the probability of cost-effectiveness that they consider acceptable. The intervention is not cost-saving to the employer.

References

Jul 1, 1990·Medical Decision Making : an International Journal of the Society for Medical Decision Making·W C Black
May 8, 1995·Journal of Health Economics·M A KoopmanschapL van Roijen
May 6, 2004·Health Economics·Elisabeth FenwickAndrew Briggs
Jun 15, 2004·Journal of Occupational and Environmental Medicine·Ronald C KesslerT Bedirhan Ustun
Jul 3, 2004·The British Journal of Psychiatry : the Journal of Mental Science·Paul McCroneAndre Tylee
Jul 20, 2004·Medical Care·Mandy van den BrinkJob Kievit
Oct 30, 2004·Scandinavian Journal of Public Health. Supplement·Kristina Alexanderson, Anders Norlund
Apr 9, 2005·BMJ : British Medical Journal·Max HendersonKevin Holland Elliott
Mar 17, 2006·Scandinavian Journal of Work, Environment & Health·J Paul Leigh
Nov 30, 2006·PLoS Medicine·Colin D Mathers, Dejan Loncar
Apr 24, 2007·Social Psychiatry and Psychiatric Epidemiology·Marjan VaezKristina Alexanderson
Jan 1, 2008·Journal of Behavioral Medicine·Pim CuijpersGerhard Andersson
Apr 2, 2010·The British Journal of Psychiatry : the Journal of Mental Science·S A H GerhardsS M A A Evers
Oct 5, 2010·The British Journal of Psychiatry : the Journal of Mental Science·Sandra HollinghurstDavid Kessler
Dec 21, 2010·Journal of Medical Internet Research·Lisanne WarmerdamPim Cuijpers
Sep 20, 2011·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Anders GustavssonUNKNOWN CDBE2010Study Group
Apr 3, 2012·Clinical Psychology Review·Derek Richards, Thomas Richardson
Mar 6, 2013·Journal of Occupational Health Psychology·Andrew C H Szeto, Keith S Dobson
Feb 6, 2014·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Gerhard Andersson, Nickolai Titov
May 24, 2014·Journal of Occupational and Environmental Medicine·Johanna M van DongenJudith E Bosmans

❮ Previous
Next ❯

Citations

Nov 8, 2017·Journal of Occupational and Environmental Medicine·Aikaterini GrimaniMalin Lohela-Karlsson
Nov 10, 2017·Workplace Health & Safety·Geunjae Lee
Aug 4, 2018·The British Journal of Psychiatry : the Journal of Mental Science·Stephanie NobisHeleen Riper

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.